The Role of Mitochondria, Oxidative Stress and Altered Calcium Homeostasis in Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Treatments

Front Cover
Manoj Kumar Jaiswal
Frontiers Media SA, Apr 17, 2017

 Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, devastating and fatal disease characterized by selective loss of upper and lower motor neurons of the cerebral cortex, brainstem, spinal cord and muscle atrophy. In spite of many years of research, the pathogenesis of ALS is still not well understood. ALS is a multifaceted genetic disease, in which genetic susceptibility to motor neuron death interacts with environmental factors and there is still no cure for this deleterious disease. At present, there is only one FDA approved drug, Riluzole which according to past studies only modestly slows the progression of the disease, and improves survival by up to three months. The suffering of the ALS patients, and their families is enormous and the economic burden is colossal. There is therefore a pressing need for new therapies.

Different molecular pathways and pathological mechanisms have been implicated in ALS. According to past studies, altered calcium homeostasis, abnormal mitochondrial function, protein misfolding, axonal transport defects, excessive production of extracellular superoxide radicals, glutamate-mediated excitotoxicity, inflammatory events, and activation of oxidative stress pathways within the mitochondria and endoplasmic reticulum can act as major contributor that eventually leads to loss of connection between muscle and nerve ultimately resulting to ALS. However, the detailed molecular and cellular pathophysiological mechanisms and origin and temporal progression of the disease still remained elusive. Ongoing research and future advances will likely advance our improve understanding about various involved pathological mechanism ultimately leading to discoveries of new therapeutic cures. Importantly, clinical biomarkers of disease onset and progression are thus also urgently needed to support the development of the new therapeutic agents and novel preventive and curative strategies. Effective translation from pre-clinical to clinical studies will further require extensive knowledge regarding drug activity, bioavailability and efficacy in both the pre-clinical and clinical setting, and proof of biological activity in the target tissue. 

During the last decades, the development of new therapeutic molecules, advance neuroimaging tools, patient derived induced stem cells and new precision medicine approaches to study ALS has significantly improved our understanding of disease. In particular, new genetic tools, neuroimaging methods, cellular probes, biomarker study and molecular techniques that achieve high spatiotemporal resolution have revealed new details about the disease onset and its progression. In our effort to provide the interested reader, clinician and researchers a comprehensive summaries and new findings in this field of ALS research, hereby we have created this electronic book which comprises of twenty seven chapters having various reviews, perspective and original research articles. All these chapters and articles in this book not only summarize the cutting-edge techniques, approaches, cell and animal models to study ALS but also provide unprecedented coverage of the current developments and new hypothesis emerging in ALS research. Some examples are novel genetic and cell culture based models, mitochondria-mediated therapy, oxidative stress and ROS mechanism, development of stem cells and mechanism-based therapies as well as novel biomarkers for designing and testing effective therapeutic strategies that can benefit ALS patients who are at the earlier stages in the disease.

I am extremely grateful to all the contributors to this book and want to thank them for their phenomenal efforts.


Manoj Kumar Jaiswal, Ph.D.                                                                       February 5, 2017

                                                                                                                   New York, NY


 

Contents

the good the bad and the ugly
7
The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
9
Riluzole But Not Melatonin Ameliorates Acute Motor Neuron Degeneration and Moderately Inhibits SOD1Mediated Excitotoxicity Induced Disrupte...
26
Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
40
Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability
47
Compartmentdependent mitochondrial alterations in experimental ALS the effects of mitophagy and mitochondriogenesis
53
Gly482Ser PGC1 4 Gene Polymorphism and ExerciseRelated Oxidative Stress in Amyotrophic Lateral Sclerosis Patients
78
Converging Paths on the Road to Motor Neuron Degeneration
89
Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cor...
168
Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis
180
Comparison of dendritic calcium transients in juvenile wild type and SOD1G93A mouse lumbar motoneurons
189
importance in nonSOD1 ALS
202
Reactive oxygen species trigger motoneuron death in noncellautonomous models of ALS through activation of cAbl signaling
208
potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia
228
NSC34 Motor NeuronLike Cells Are Unsuitable as Experimental Model for GlutamateMediated Excitotoxicity
236
Hanging on for Dear Life
248

CIIA prevents SOD1G93Ainduced cytotoxicity by blocking ASK1mediated signaling
105
GNX4728 a novel small molecule drug inhibitor of mitochondrial permeability transition is therapeutic in a mouse model of amyotrophic lateral scle...
111
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
118
Activation of the endoplasmic reticulum stress response in skeletal muscle of G93ASOD1 amyotrophic lateral sclerosis mice
126
integration of findings from motor neuron somata and motor terminals
140
temporal trends in respiration oxidation and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice
145
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
156
Gene expression profiling for human iPSderived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial funct...
260
Perspectives on the Deadly Mitochondria ER Stress and Calcium Triad
285
Dysregulated expression of death stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotr...
311
Promise and Pitfalls of Mitochondrial Replacement for Prevention and Cure of Heritable Neurodegenerative Diseases Caused by Deleterious Mutation...
331
Back cover
337
Copyright

Common terms and phrases

Bibliographic information